“We'll experience at least another 10 weeks of vaccine shortage,” Germany’s Health Minister Jens Spahn said on Thursday.
This comes after reports said last week that the EU would get 60% fewer doses of the vaccine than promised for January-March 2021.
A meeting between the European Health Commissioner Stella Kyriakides and AstraZeneca CEO Pascal Soriot held on Wednesday, failed to secure commitments from the drug maker to address a “massive” shortfall in coronavirus vaccine production.
Kyriakides said: “We regret the continued lack of clarity on the delivery schedule and request a clear plan from AstraZeneca for the fast delivery of the quantity of vaccines that we reserved for Q1.”
Meanwhile, Soriot blamed the EU for being three months slower than the UK in finalizing its purchase agreements for the vaccine, earlier this week.
Separately, Germany’s Interior Ministry confirmed that Europe’s top economy is preparing entry restrictions for travellers from the UK, Brazil and South Africa.
The above comments are not going to go down too well, as the market sentiment remains tepid amid mounting covid and global growth concerns.
EUR/USD was last seen trading at 1.2092, down 0.12% on the day, as the safe-haven dollar remains broadly bid amid risk-averse market conditions.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.